生物製药辅料市场规模、份额和成长分析（按产品、功能、应用、最终用户和地区划分）—2026-2033年产业预测

全球生物製药辅料市场规模预计在 2024 年达到 24.3 亿美元，从 2025 年的 25.7 亿美元增长到 2033 年的 39.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.6%。

受生物製药需求成长、个人化医疗理念日益受到重视以及生物技术领域显着进步的推动，全球生物製药辅料市场正经历强劲成长。癌症和自体免疫疾病等慢性病的流行促使人们更加需要标靶治疗，也使得特殊辅料在提高药物疗效和减少副作用方面的作用更加凸显。此外，从传统小分子药物转变为生物製药的转变进一步推动了对这些辅料的需求。然而，该市场仍面临诸多挑战，包括复杂的法规环境导致核准流程繁琐并增加了营运成本。此外，生物製药辅料的高成本，且依赖先进技术和专业生产设施，也限制了其广泛应用。

推动全球生物製药辅料市场发展的因素

慢性病发病率的上升和人口老化的加剧显着增加了对生物製药产品的需求。由于生物製药能够提供个人化和高效的治疗方案，对专用辅料的需求也随之增强。这些辅料在提高复杂药物产品的稳定性、溶解度和递送效率方面发挥关键作用，推动了生物製药辅料市场的扩张。随着医疗机构越来越重视有效的治疗方法，创新型辅料的重要性日益凸显，进一步促进了生物製药产业这个充满活力的细分领域的整体成长和发展。

全球生物製药辅料市场面临的限制因素

全球生物製药辅料市场面临许多限制因素，其中生物製药核准流程的严格性和复杂性尤其突出。生物製药辅料的广泛测试和检验要求对生产者构成了一大障碍。遵守各项监管标准极具挑战性，最终可能阻碍市场成长。随着市场对高品质辅料的需求不断增长，生产商必须在确保严格合规的同时进行创新，这是他们必须应对的双重挑战，才能充分掌握市场机会。

生物製药辅料市场的全球趋势

全球生物製药辅料市场正呈现一个显着趋势：对旨在满足生物製药製剂特定需求的特种功能辅料的需求日益增长。随着生物製药领域的拓展和发展，人们对具有先进功能的辅料越来越感兴趣，例如蛋白质稳定、药物控释机制和增强溶解度。这些特殊辅料有助于开发更有效、更有效率的药物递送系统，推动创新并协助复杂生物製药製剂的配製。这一趋势反映了生物製药行业向个人化和客製化治疗的广泛转变。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球生物製药辅料市场规模（依产品划分）及复合年增长率（2026-2033 年）

• 碳水化合物
  • 葡萄糖
  • 淀粉
  • 蔗糖
• 多元醇类
  • 甘露醇
  • 山梨醇
• 增溶剂、界面活性剂、乳化剂
  • 酯类
  • 三酸甘油酯
• 特殊辅料

全球生物製药辅料市场规模（依功能划分）及复合年增长率（2026-2033 年）

• 粘合剂
• 涂层剂
• 崩坏
• 润滑剂和拖鞋
• 医药填充剂
• 防腐剂

全球生物製药辅料市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 先进交付系统
• 口服
• 肠外
• 外用药物

全球生物製药辅料市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 契约製造公司
• 製药和生物技术公司

全球生物製药辅料市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Merck KGaA（Germany）
• BASF SE（Germany）
• Evonik Industries AG（Germany）
• Roquette Freres（France）
• Colorcon, Inc.（USA）
• DFE Pharma（Germany）
• Avantor, Inc.（USA）
• Kerry Group plc（Ireland）
• Associated British Foods plc（UK）
• Wacker Chemie AG（Germany）
• Lubrizol Corporation（USA）
• J. Rettenmaier & Sohne GmbH+Co KG（Germany）
• SPI Pharma（USA）
• Fuji Chemical Industries Co., Ltd.（Japan）
• Meggle GmbH & Co. KG（Germany）
• Beneo GmbH（Germany）

结论与建议

Global Biopharmaceuticals Excipients Market size was valued at USD 2.43 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 3.97 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global biopharmaceuticals excipients market is witnessing robust growth, driven by the rising demand for biopharmaceutical drugs, increased emphasis on personalized medicine, and notable advancements in biotechnology. The prevalence of chronic conditions, such as cancer and autoimmune diseases, has intensified the need for targeted treatments, elevating the role of specialized excipients in enhancing drug efficacy and reducing side effects. Moreover, the transition towards biologics over traditional small molecules further fuels demand for these excipients. However, the market faces challenges, including a complex regulatory environment that complicates the approval processes and escalates operational costs. Additionally, the high costs associated with manufacturing biopharmaceutical excipients limit broader adoption, given their reliance on advanced technologies and specialized production facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Excipients Market Segments Analysis

Global Biopharmaceuticals Excipients Market is segmented by Product, Function, Application, End User and region. Based on Product, the market is segmented into Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers and Specialty Excipients. Based on Function, the market is segmented into Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers and Preservatives. Based on Application, the market is segmented into Advanced Delivery System, Oral, Parenteral and Topical. Based on End User, the market is segmented into Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Excipients Market

The growing incidence of chronic illnesses, alongside an expanding elderly demographic, has significantly boosted the demand for biopharmaceutical products. Biologics provide tailored and more efficient treatment options, which in turn heightens the necessity for specialized excipients. These excipients play a crucial role in improving the stability, solubility, and delivery of these complex medications, thereby fueling the expansion of the biopharmaceutical excipients market. As healthcare providers increasingly prioritize effective treatment modalities, the importance of innovative excipients continues to rise, contributing to the overall growth and evolution of this dynamic sector within the biopharmaceutical industry.

Restraints in the Global Biopharmaceuticals Excipients Market

The Global Biopharmaceuticals Excipients market faces significant constraints due to the stringent and intricate approval processes for biopharmaceutical drugs. The thorough testing and validation requirements for excipients utilized in biologic formulations create obstacles for manufacturers. Navigating through a range of regulatory standards can be quite challenging, which may ultimately impede the growth of the market. As the demand for high-quality excipients increases, manufacturers must ensure rigorous compliance while also innovating, thereby presenting a dual challenge that needs to be addressed to fully capitalize on opportunities within the market landscape.

Market Trends of the Global Biopharmaceuticals Excipients Market

The Global Biopharmaceuticals Excipients market is witnessing a significant trend towards the increased demand for specialty and functional excipients designed to meet the specific needs of biopharmaceutical formulations. As the biologics sector expands and evolves, there is a marked interest in excipients that offer enhanced functionalities, including protein stabilization, controlled drug release mechanisms, and improved solubility. These specialized excipients facilitate the development of more effective and efficient drug delivery systems, driving innovation and supporting the formulation of complex biologic products. This trend reflects the broader shift towards personalized and tailored therapeutics in the biopharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Excipients Market Size by Product & CAGR (2026-2033)

• Market Overview
• Carbohydrates
  • Dextrose
  • Starch
  • Sucrose
• Polyols
  • Mannitol
  • Sorbitol
• Solubilizers & Surfactants/Emulsifiers
  • Esters
  • Triglycerides
• Specialty Excipients

Global Biopharmaceuticals Excipients Market Size by Function & CAGR (2026-2033)

• Market Overview
• Binders
• Coatings
• Disintegrants
• Lubricants & glidants
• Pharmaceutical Fillers
• Preservatives

Global Biopharmaceuticals Excipients Market Size by Application & CAGR (2026-2033)

• Market Overview
• Advanced Delivery System
• Oral
• Parenteral
• Topical

Global Biopharmaceuticals Excipients Market Size by End User & CAGR (2026-2033)

• Market Overview
• Contract Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Global Biopharmaceuticals Excipients Market Size & CAGR (2026-2033)

• North America (Product, Function, Application, End User)
  • US
  • Canada
• Europe (Product, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lubrizol Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Rettenmaier & Sohne GmbH + Co KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meggle GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beneo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations